Risk of breast cancer in women initiating insulin glargine compared with insulin detemir Or NPH insulin

被引：0
|
作者：
Bradley, Marie C. [1 ]
Chillarige, Yoganand [2 ]
Lee, Hana [1 ]
Wu, Xiyuan [1 ]
Bright, Patricia [1 ]
Parulekar, Shruti [2 ]
Wernecke, Michael [2 ]
Soukup, Mat [1 ]
Kelman, Jeffrey A. [3 ]
Graham, David J. [1 ]
机构：
[1] Food & Drug Adm, Silver Spring, MD USA
[2] Acumen LLC, Burlingame, CA USA
[3] Ctr Medicare & Medicaid Serv, Washington, DC USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
316
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [1] Risk of breast cancer in patients exposed to insulin glargine compared to human NPH insulin.
    Boyle, Peter
    Wu, Chuntao
    Sharma, Kristen
    Lin, Stephen
    Juhaeri, Juhaeri
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] No Increased Risk of Breast Cancer in Patients Exposed to Insulin Glargine Compared with Human NPH Insulin
    Boyle, Peter
    Wu, Chuntao
    Sharma, Kristen
    Lin, Stephen L.
    Juhaeri, Juhaeri
    [J]. DIABETES, 2018, 67
  • [3] Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir
    Peterson, Gregory E.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (12) : 2613 - 2619
  • [4] Lower within-subject variability of insulin detemir compared to NPH insulin and insulin glargine in subjects with Type 1 diabetes.
    Heise, T
    Nosek, L
    Draeger, E
    Ronn, BB
    Kapitza, C
    Heinemann, L
    [J]. DIABETOLOGIA, 2003, 46 : A6 - A7
  • [5] Insulin detemir provides superior glycaemic control compared with NPH insulin
    Larsen, J. J.
    Heller, S.
    Pedersen, C. B.
    [J]. DIABETOLOGIA, 2007, 50 : S393 - S394
  • [6] Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin
    Stuermer, Til
    Marquis, M. Alison
    Zhou, Haibo
    Meigs, James B.
    Lim, Soo
    Blonde, Lawrence
    MacDonald, Eileen
    Wang, Ray
    LaVange, Lisa M.
    Pate, Virginia
    Buse, John B.
    [J]. DIABETES CARE, 2013, 36 (11) : 3517 - 3525
  • [7] INSULIN GLARGINE COMPARED TO INSULIN NPH FOR THE MANAGEMENT OF HYPERGLYCEMIA IN THE CRITICALLY ILL
    Trang, Joseph
    Fox, Marlena
    Danesh, Valerie
    Jones, Timothy
    [J]. CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [8] Insulin detemir improves glycemic control with reduced risk of hypoglycemia and weight loss in patients previously treated with insulin glargine or NPH insulin
    Meneghini, Luigi
    Koenen, Christoph
    Rojas, Patrick
    Selam, Jean-Louis
    [J]. DIABETES, 2007, 56 : A573 - A573
  • [9] Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes
    Robertson, K. J.
    Schoenle, E.
    Gucev, Z.
    Mordhorst, L.
    Gall, M. -A.
    Ludvigsson, J.
    [J]. DIABETIC MEDICINE, 2007, 24 (01) : 27 - 34
  • [10] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with Type 1 diabetes
    Kolendorf, K
    Prasek, M
    Santeusanio, F
    Philotheou, A
    Gall, MA
    Heller, S
    [J]. DIABETOLOGIA, 2004, 47 : A329 - A329
12345